Table of Contents:
- Integrating immunotherapy in the treatment paradigm for early-stage non-small cell lung cancer
- Immune checkpoint inhibition: a game-changer in the treatment of malignant pleural mesothelioma
- Immune checkpoint inhibition in kidney transplant recipients
- Immunotherapy for gastro-oesophageal cancers
- The gut microbiome: a predictive biomarker for a response to immune checkpoint inhibition?
